Whipple's Disease and Interleukins
Whipple's Disease and Interleukins is a research topic within Pathology and Forensic Medicine. Science Explorer counts 5.1k research works in it since 1950. 17.6% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the pathogenesis, diagnosis, and treatment of Whipple's disease, caused by the bacterium Tropheryma whipplei. It covers topics such as bacterial cultivation, genome sequencing, interleukin-16 involvement, central nervous system manifestations, PCR diagnosis, microbial susceptibility to antibiotics, and the immune reconstitution inflammatory syndrome. The research also delves into the association of Whipple's disease with immunosuppressive therapy and explores potential genetic biomarkers for disease susceptibility.
- Whipple's Disease
- Tropheryma whipplei
- Interleukin-16
- Bacterial Cultivation
- Genome Sequencing
- Immunosuppressive Therapy
- Central Nervous System Involvement
- PCR Diagnosis
- Microbial Susceptibility
- Immune Reconstitution Inflammatory Syndrome
- Research works
- 5.1k fractional, since 1950
- In the world top 10%
- 898 per year above
- Top-10% rate
- 17.6% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +7% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Whipple's Disease and Interleukins research?
By volume, the United States and China publish the most (168 and 130 works in 2022–2025).
By volume, 2022–2025
- 1 United States 168 works
- 2 China 130 works
- 3 Germany 46 works
- 4 India 43 works
- 5 Brazil 42 works
- 6 Italy 38 works
- 7 France 38 works
- 8 United Kingdom 31 works
- 9 Spain 21 works
- 10 Australia 19 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Whipple's Disease and Interleukins research?
By volume in 2022–2025, Charité - Universitätsmedizin Berlin publishes the most Whipple's Disease and Interleukins research, followed by Rush University Medical Center and University of Padua.
By volume, 2022–2025
- 1 Charité - Universitätsmedizin BerlinGermany 4 works
- 2 Rush University Medical CenterUnited States 3 works
- 3 University of PaduaItaly 3 works
- 4 Zhejiang UniversityChina 3 works
- 5 University of BaghdadIraq 3 works
- 6 Mayo ClinicUnited States 3 works
- 7 Ludwig-Maximilians-Universität MünchenGermany 3 works
- 8 Chinese Academy of Medical Sciences & Peking Union Medical CollegeChina 3 works
- 9 Ural State Medical UniversityRussia 2 works
- 10 Sichuan UniversityChina 2 works
Who are the leading researchers in Whipple's Disease and Interleukins?
The most-cited researchers publishing on Whipple's Disease and Interleukins include Didier Raoult.
- 1 Didier Raoult France 2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Whipple's Disease and Interleukins research done?
The largest centres of Whipple's Disease and Interleukins research in 2022–2025 are Beijing (China), Paris (France), London (United Kingdom) and New York (United States).
Is Whipple's Disease and Interleukins research growing?
Output in 2018–2022 was 7% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Whipple's Disease and Interleukins.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.